| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.614 | 0.004 | 0.614 | Insulin secretagoues | 0.606 0.004 CID_130939 | ||
| 0.603 | 0.008 | 0.635 | Hypoglycemic | 0.635 0.006 CID_130939 | CID_130939 | |
| 0.397 | 0.029 | 0.397 | Cardiotonic | 0.375 0.033 CID_130939 | ||
| 0.387 | 0.103 | 0.387 | Beta lactamase inhibitor | |||
| 0.38 | 0.102 | 0.503 | Cyclophilin D inhibitor | 0.503 0.049 CID_130939 | CID_130939 | |
| 0.205 | 0.004 | 0.205 | Potassium channel (ATP-sensitive) blocker | 0.163 0.004 CID_130939 | ||
| 0.246 | 0.074 | 0.256 | Platelet antagonist | 0.256 0.07 CID_130939 | CID_130939 | |
| 0.124 | 0.006 | 0.124 | Bombesin 3 receptor antagonist | 0.115 0.008 CID_130939 | ||
| 0.13 | 0.014 | 0.13 | Lipase inhibitor | 0.117 0.019 CID_130939 | ||
| 0.105 | 0.006 | 0.166 | Potassium channel (Inward rectifier) blocker | 0.166 0.004 CID_130939 | CID_130939 | |
| 0.102 | 0.01 | 0.102 | CC chemokine 3 receptor antagonist | 0.083 0.013 CID_130939 | ||
| 0.161 | 0.071 | 0.161 | Anticoagulant | 0.147 0.083 CID_130939 | ||
| 0.09 | 0.005 | 0.09 | Carbonic anhydrase I stimulant | 0.08 0.007 CID_130939 | ||
| 0.086 | 0.008 | 0.086 | Carbonic anhydrase II stimulant | 0.079 0.01 CID_130939 | ||
| 0.204 | 0.127 | 0.204 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.1 | 0.025 | 0.1 | Thrombin inhibitor | 0.089 0.033 CID_130939 | ||
| 0.096 | 0.03 | 0.096 | Cannabinoid receptor antagonist | 0.063 0.059 CID_130939 | ||
| 0.17 | 0.115 | 0.17 | Potassium channel blocker | 0.143 0.142 CID_130939 | ||
| 0.088 | 0.035 | 0.088 | Epoxide hydrolase inhibitor | 0.073 0.049 CID_130939 | ||
| 0.042 | 0.008 | 0.042 | Epoxide hydrolase 2 inhibitor | 0.03 0.014 CID_130939 | ||
| 0.098 | 0.065 | 0.098 | Chemokine receptor antagonist | |||
| 0.064 | 0.036 | 0.064 | Carbonic anhydrase stimulant | 0.052 0.051 CID_130939 | ||
| 0.062 | 0.041 | 0.062 | Cannabinoid CB1 receptor agonist | |||
| 0.051 | 0.031 | 0.051 | Collagenase inhibitor | 0.047 0.038 CID_130939 | ||
| 0.056 | 0.04 | 0.073 | Beta 1 adrenoreceptor antagonist | 0.073 0.023 CID_130939 | CID_130939 | |
| 0.058 | 0.045 | 0.058 | Bcl-xL inhibitor | 0.057 0.051 CID_130939 | ||
| 0.018 | 0.008 | 0.018 | Carbonic anhydrase IV stimulant | 0.016 0.01 CID_130939 | ||
| 0.058 | 0.047 | 0.058 | Cannabinoid CB1 receptor antagonist | |||
| 0.016 | 0.008 | 0.016 | CC chemokine 10 receptor antagonist | |||
| 0.042 | 0.034 | 0.046 | Purinergic P2Y antagonist | 0.046 0.03 CID_130939 | CID_130939 | |
| 0.037 | 0.029 | 0.037 | Potassium channel Kv1.1 blocker | |||
| 0.07 | 0.064 | 0.083 | Somatostatin 1 agonist | 0.083 0.048 CID_130939 | CID_130939 | |
| 0.044 | 0.043 | 0.044 | Matrix metalloproteinase 1 inhibitor | |||
| 0.017 | 0.03 | 0.025 | Beta 1 adrenoreceptor agonist | 0.025 0.012 CID_130939 | CID_130939 | |
| 0.035 | 0.058 | 0.049 | Prostaglandin E2 antagonist | 0.049 0.036 CID_130939 | CID_130939 | |
| 0.036 | 0.06 | 0.046 | Beta 2 adrenoreceptor antagonist | 0.046 0.042 CID_130939 | CID_130939 | |
| 0.176 | 0.211 | 0.211 | Antithrombotic | 0.211 0.165 CID_130939 | CID_130939 | |
| 0.037 | 0.082 | 0.045 | Beta adrenoreceptor agonist | 0.045 0.031 CID_130939 | CID_130939 | |
| 0.043 | 0.098 | 0.061 | Beta adrenoreceptor antagonist | 0.061 0.053 CID_130939 | CID_130939 | |
| 0.05 | 0.122 | 0.059 | Prolactin release inhibitor | 0.059 0.056 CID_130939 | CID_130939 | |
| 0.047 | 0.132 | 0.082 | Adrenaline agonist | 0.082 0.055 CID_130939 | CID_130939 | |
| 0.218 | 0.308 | 0.294 | Antiinflammatory | 0.294 0.221 CID_130939 | CID_130939 | |
| 0.045 | 0.155 | 0.059 | Beta 2 adrenoreceptor agonist | 0.059 0.056 CID_130939 | CID_130939 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |